InfuSystem Holdings INFU Device Solutions — Lease revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by InfuSystem Holdings in its filing.
Tagged under the XBRL concept us-gaap:LeaseIncome.
The official record: InfuSystem Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about InfuSystem Holdings's device solutions — lease revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is InfuSystem Holdings's device solutions — lease revenue?
- InfuSystem Holdings (INFU) reported device solutions — lease revenue of $5.3M in Q1 2026.
- How has InfuSystem Holdings's device solutions — lease revenue changed year-over-year?
- InfuSystem Holdings's device solutions — lease revenue decreased by 7.5% year-over-year, from $5.74M to $5.3M.
- What is the long-term trend for InfuSystem Holdings's device solutions — lease revenue?
- Over 4 years (2021 to 2025), InfuSystem Holdings's device solutions — lease revenue has grown at a 7.0% compound annual growth rate (CAGR), from $16.77M to $22.01M.
- What does device solutions — lease revenue mean?
- Revenue generated specifically from the leasing of medical equipment to healthcare providers and clinics. This reflects the recurring income stream derived from the rental model of the Device Solutions segment.